What amount sold does STANDARD EULER, INC. report in Form D filings?

The latest linked filings report $20.8M sold across 7 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was STANDARD EULER, INC.'s most recent SEC filing?

STANDARD EULER, INC.'s most recent Form D filing was on 2026-04-10.

How many investors does STANDARD EULER, INC. have?

The most recent Form D filing lists 4 investor(s).

What type of securities does STANDARD EULER, INC. offer?

STANDARD EULER, INC.'s SEC Form D filings indicate equity offerings.

STANDARD EULER, INC.

CIK: 0001654483·Other·Newark, NJ·Corporation

Reported Sold

$20,753,748

Total Filings

Identified Offerings

Last Filed

Apr 10, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other industry

SEC EDGAR

Offering filing timeline

Apr 10, 2026Form D — New notice

Reported sold: $5,700,000 · Target: $6,000,000

Rule 506(b)·4 investors

Oct 17, 2024Form D/A — Amendment

Reported sold: $11,283,549 · Target: $12,783,548

Rule 506(b)·24 investors

Changed: Reported amount sold, Offering target, Reported investors

Jul 28, 2022Form D/A — Amendment

Reported sold: $8,783,550 · Target: $8,783,550

Rule 506(b)·20 investors

Changed: Reported amount sold, Offering target, Reported investors

Apr 27, 2022Form D — New notice

Reported sold: $5,683,548 · Target: $8,183,545

Rule 506(b)·18 investors

Mar 16, 2022Form D — New notice

Reported sold: $108,548 · Target: $108,548

Rule 506(b)·2 investors

Mar 30, 2021Form D — New notice

Reported sold: $1,075,000 · Target: $1,200,000

Rule 506(b)·9 investors

Dec 22, 2020Form D — New notice

Reported sold: $100,000 · Target: $100,000

Rule 506(b)·2 investors

Jan 8, 2019Form D — New notice

Reported sold: $2,061,651 · Target: $3,451,650

Rule 506(b)·15 investors

Oct 13, 2015Form D — New notice

Reported sold: $425,000 · Target: $700,000

Rule 506(b)·3 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

22%

Latest reported sold across 7 identified offerings

$20,753,748

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Daniel Myers

Related Person

Appears on 7 filings

Kenny Tay

Related Person

Appears on 7 filings

Andrew Dai

Related Person

Appears on 3 filings

Edward Paget

Related Person

Appears on 3 filings

Mike Winterfield

Related Person

Appears on 2 filings

Hector MacQuarrie

Related Person

Appears on 1 filing

Daniel Myers

Related Person

Appears on 1 filing

Kenny Tay

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Apr 10, 2026	New	$6,000,000	$5,700,000	4
Oct 17, 2024	Amendment	$12,783,548	$11,283,549	24
Jul 28, 2022	Amendment	$8,783,550	$8,783,550	20
Apr 27, 2022	New	$8,183,545	$5,683,548	18
Mar 16, 2022	New	$108,548	$108,548	2
Mar 30, 2021	New	$1,200,000	$1,075,000	9
Dec 22, 2020	New	$100,000	$100,000	2
Jan 8, 2019	New	$3,451,650	$2,061,651	15
Oct 13, 2015	New	$700,000	$425,000	3

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

iQure Pharma Inc.

Other

Offering target: $4,000,000

Filed Sep 21, 2026